Cite
HARVARD Citation
Agache, I. et al. (2020). Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Allergy. 75 (5), pp. 1043-1057. [Online].